First pediatric trial tests new brain tumor drug after standard treatments fail
Disease control
Completed
This study tested the safety and side effects of an experimental drug called Tovorafenib (DAY101) in children and young adults with recurrent low-grade brain tumors that didn't respond to standard treatments. Researchers wanted to find the highest dose children could tolerate wit…
Phase: PHASE1 • Sponsor: Karen D. Wright, MD • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC